Tolerability, pharmacokinetics and pharmacodynamics of high single-ascending doses of ticagrelor in volunteers
Latest Information Update: 11 Nov 2013
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes; Coronary artery disease; Peripheral arterial disorders
- Focus Adverse reactions
- Sponsors AstraZeneca
- 11 Nov 2013 New trial record
- 17 Sep 2013 Results published in the International Journal of Clinical Pharmacology and Therapeutics.